Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: MRR

Global Electronic Nose Strategic Business Report 2023: 36 Players Featured Including MYDX, Odotech, Olfaguard and Plasmion


DUBLIN, Feb. 1, 2023 /PRNewswire/ -- The "Electronic Nose - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global market for Electronic Nose estimated at US$19 Million in the year 2022, is projected to reach a revised size of US$47.1 Million by 2030, growing at a CAGR of 12% over the analysis period 2022-2030.

Environmental Monitoring, one of the segments analyzed in the report, is projected to record a 12.7% CAGR and reach US$20.2 Million by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Food & Beverage segment is readjusted to a revised 11.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.6 Million, While China is Forecast to Grow at 11.1% CAGR

The Electronic Nose market in the U.S. is estimated at US$5.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 10.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Select Competitors (Total 36 Featured) -

What`s New for 2023?

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/qxv332-nose?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

24 avr 2024
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

24 avr 2024
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

24 avr 2024
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...



News published on and distributed by: